4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Rheumatic Heart Disease
Rheumatic heart disease (RHD) is a long-term consequence of rheumatic fever, an inflammatory disease that can develop after a strep throat or scarlet fever infection. When left untreated, the inflammation caused by rheumatic fever can damage the heart valves, leading to complications such as valve stenosis or regurgitation. While the disease was once common in many parts of the world, its prevalence has decreased significantly in developed countries due to widespread use of antibiotics to treat strep throat. However, RHD remains a major concern in low- and middle-income nations, where access to medical care and prevention programs is limited. Early detection and appropriate treatment of streptococcal throat infections are crucial in preventing the development of rheumatic heart disease.
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Federico Benetti
Benetti Foundation, Argentina
Uwe Peter Tigor
Auxilius Pharma, United States
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Praveen Veerabhadrappa
Penn State University, United States
Faizan Butt
Rutgers Jersey City Medical Center, United StatesSubmit your abstract Today
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Beyond PCSK9: The next wave of lipid-lowering and thrombosis prevention - from bench to breakthrough
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Current approaches to anti-angina drug treatment in Chronic-stable Angina Pectoris (CSAP) in US primary care and cardiology – A cross-sectional, blinded standard-of-care survey
Uwe Peter Tigor, Auxilius Pharma, United States